BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 18618599)

  • 21. Retracted: Nestin Regulates Keap1-Nrf2-HO-1-Mediated Antioxidant Responses during Stress and Malignant Hematopoiesis.
    International BR
    Biomed Res Int; 2023; 2023():9765743. PubMed ID: 38075336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents.
    Giudice A; Arra C; Turco MC
    Methods Mol Biol; 2010; 647():37-74. PubMed ID: 20694660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution.
    Taguchi K; Motohashi H; Yamamoto M
    Genes Cells; 2011 Feb; 16(2):123-40. PubMed ID: 21251164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of Nrf2-an update.
    Niture SK; Khatri R; Jaiswal AK
    Free Radic Biol Med; 2014 Jan; 66():36-44. PubMed ID: 23434765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism.
    Loboda A; Damulewicz M; Pyza E; Jozkowicz A; Dulak J
    Cell Mol Life Sci; 2016 Sep; 73(17):3221-47. PubMed ID: 27100828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional Regulation by Nrf2.
    Tonelli C; Chio IIC; Tuveson DA
    Antioxid Redox Signal; 2018 Dec; 29(17):1727-1745. PubMed ID: 28899199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nrf2-Keap1 signaling in oxidative and reductive stress.
    Bellezza I; Giambanco I; Minelli A; Donato R
    Biochim Biophys Acta Mol Cell Res; 2018 May; 1865(5):721-733. PubMed ID: 29499228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors.
    Singh A; Venkannagari S; Oh KH; Zhang YQ; Rohde JM; Liu L; Nimmagadda S; Sudini K; Brimacombe KR; Gajghate S; Ma J; Wang A; Xu X; Shahane SA; Xia M; Woo J; Mensah GA; Wang Z; Ferrer M; Gabrielson E; Li Z; Rastinejad F; Shen M; Boxer MB; Biswal S
    ACS Chem Biol; 2016 Nov; 11(11):3214-3225. PubMed ID: 27552339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural basis of Keap1 interactions with Nrf2.
    Canning P; Sorrell FJ; Bullock AN
    Free Radic Biol Med; 2015 Nov; 88(Pt B):101-107. PubMed ID: 26057936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis.
    Yamamoto M; Kensler TW; Motohashi H
    Physiol Rev; 2018 Jul; 98(3):1169-1203. PubMed ID: 29717933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of NRF2-mediated gene expression by dietary phytochemical flavones apigenin and luteolin.
    Paredes-Gonzalez X; Fuentes F; Jeffery S; Saw CL; Shu L; Su ZY; Kong AN
    Biopharm Drug Dispos; 2015 Oct; 36(7):440-51. PubMed ID: 25904312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinoic acid synergizes ATO-mediated cytotoxicity by precluding Nrf2 activity in AML cells.
    Valenzuela M; Glorieux C; Stockis J; Sid B; Sandoval JM; Felipe KB; Kviecinski MR; Verrax J; Buc Calderon P
    Br J Cancer; 2014 Aug; 111(5):874-82. PubMed ID: 25003661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of the evidence that ochratoxin A is an Nrf2 inhibitor: implications for nephrotoxicity and renal carcinogenicity.
    Limonciel A; Jennings P
    Toxins (Basel); 2014 Jan; 6(1):371-9. PubMed ID: 24448208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabine.
    Duong HQ; Yi YW; Kang HJ; Hong YB; Tang W; Wang A; Seong YS; Bae I
    Int J Oncol; 2014 Mar; 44(3):959-69. PubMed ID: 24366069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of oxidative stress as an anticancer strategy.
    Gorrini C; Harris IS; Mak TW
    Nat Rev Drug Discov; 2013 Dec; 12(12):931-47. PubMed ID: 24287781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptomic alterations induced by Ochratoxin A in rat and human renal proximal tubular in vitro models and comparison to a rat in vivo model.
    Jennings P; Weiland C; Limonciel A; Bloch KM; Radford R; Aschauer L; McMorrow T; Wilmes A; Pfaller W; Ahr HJ; Slattery C; Lock EA; Ryan MP; Ellinger-Ziegelbauer H
    Arch Toxicol; 2012 Apr; 86(4):571-89. PubMed ID: 22124623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A genome-wide survey of imprinted genes in rice seeds reveals imprinting primarily occurs in the endosperm.
    Luo M; Taylor JM; Spriggs A; Zhang H; Wu X; Russell S; Singh M; Koltunow A
    PLoS Genet; 2011 Jun; 7(6):e1002125. PubMed ID: 21731498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway.
    Hayes JD; McMahon M; Chowdhry S; Dinkova-Kostova AT
    Antioxid Redox Signal; 2010 Dec; 13(11):1713-48. PubMed ID: 20446772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NRF2 as a determinant of cellular resistance in retinoic acid cytotoxicity.
    Tan KP; Kosuge K; Yang M; Ito S
    Free Radic Biol Med; 2008 Dec; 45(12):1663-73. PubMed ID: 18845239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements.
    Itoh K; Chiba T; Takahashi S; Ishii T; Igarashi K; Katoh Y; Oyake T; Hayashi N; Satoh K; Hatayama I; Yamamoto M; Nabeshima Y
    Biochem Biophys Res Commun; 1997 Jul; 236(2):313-22. PubMed ID: 9240432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.